Page last updated: 2024-11-01

orphenadrine and Dementia

orphenadrine has been researched along with Dementia in 3 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROBINSON, RA1
Broe, GA1
Caird, FI1
Hall, P1

Other Studies

3 other studies available for orphenadrine and Dementia

ArticleYear
[The use of orphenadrine in aged psychiatric patients].
    Acta neurologica et psychiatrica Belgica, 1961, Volume: 61

    Topics: Aged; Dementia; Humans; Mental Disorders; Orphenadrine; Parasympatholytics; Psychotic Disorders

1961
Levodopa for parkinsonism in elderly and demented patients.
    The Medical journal of Australia, 1973, Mar-31, Volume: 1, Issue:13

    Topics: Activities of Daily Living; Aged; Cardiovascular Diseases; Dementia; Dihydroxyphenylalanine; Drug Sy

1973
Differential diagnosis and treatment of depression in the elderly.
    Gerontologia clinica, 1974, Volume: 16, Issue:1

    Topics: Adjustment Disorders; Aged; Antidepressive Agents; Circadian Rhythm; Dementia; Depression; Diagnosis

1974